Capricor Therapeutics Inc’s recent filing unveils that its 10% Owner Nippon Shinyaku Co Ltd acquired Company’s shares for reported $15.0 million on Sep 20 ’24. In the deal valued at $5.36 per share,2,798,507 shares were bought. As a result of this transaction, Nippon Shinyaku Co Ltd now holds 7,090,351 shares worth roughly $126.0 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oppenheimer initiated its Capricor Therapeutics Inc [CAPR] rating to an Outperform in a research note published on May 17, 2024; the price target was $14. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Ladenburg Thalmann began covering CAPR with “Buy” recommendation on October 26, 2022. Maxim Group revised its rating on December 26, 2018. It rated CAPR as “a Hold” which previously was an “a Buy”.
Price Performance Review of CAPR
On Friday, Capricor Therapeutics Inc [NASDAQ:CAPR] saw its stock jump 3.68% to $17.77. Over the last five days, the stock has lost -17.92%. Capricor Therapeutics Inc shares have risen nearly 263.39% since the year began. Nevertheless, the stocks have risen 527.92% over the past one year. While a 52-week high of $21.98 was reached on 10/04/24, a 52-week low of $2.68 was recorded on 08/07/24. SMA at 50 days reached $7.43, while 200 days put it at $5.69.
Levels Of Support And Resistance For CAPR Stock
The 24-hour chart illustrates a support level at 16.27, which if violated will result in even more drops to 14.76. On the upside, there is a resistance level at 19.82. A further resistance level may holdings at 21.86. The Relative Strength Index (RSI) on the 14-day chart is 68.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.09, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 28.92%. Stochastics %K at 71.67% indicates the stock is a holding.
How much short interest is there in Capricor Therapeutics Inc?
A steep rise in short interest was recorded in Capricor Therapeutics Inc stocks on 2024-09-30, dropping by -2.23 million shares to a total of 5.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 7.47 million shares. There was a decline of -42.59%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 26, 2018 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $8.60.
